Enhancement of human natural killer cytotoxic activity by vitamin C in pure and augmented formulations

Journal of Nutritional and Environmental Medicine

Volumn 7, Issue 3, 1997, Pages 187-196

  Vojdani, Aristo ^a,b   Namatalla, Galal ^b  

^a Immunosciences Laboratories Inc   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Natural killer cell; Ultra Potent C; Vitamin C

Indexed keywords

ASCORBIC ACID;

ADULT; ARTICLE; CELL ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; MALE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TIME; VITAMIN BLOOD LEVEL;

EID: 0030771053     PISSN: 13590847     EISSN: None     Source Type: Journal    
DOI: 10.1080/13590849762600     Document Type: Article

References (29)

1. Barnes MJ, Kodicek E. Biological hydroxylations and ascorbic acid with special regard to collagen metabolism. Vitamin Horm 1972; 30: 1-43.
2. Thomas TN, Zemp JW. Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid. J Neurochem 1977; 28: 663-5.
3. Dogkwitz E, Walsch S, Dubberstein M, Winter J. Ascorbic acid and cytochromes. Ann NY Acad Sci 1975; 258: 201-8.
4. Henson DE, Block G, Levine M. Ascorbic acid: biologic functions and relation to cancer. J Nat Cancer Inst 1991; 83: 547-50.
5. Chan WC, Fong YY. Ascorbic acid prevents liver tumor production by aminopyrine and nitrite in the rat. Int J Cancer 1977; 20: 268-70.
6. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer; prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1976; 73: 3685-9.
7. Edgar JA. Ascorbic acid and biological alkylating agents. Nature Lond 1974; 248: 136-7.
8. Kamm JJ, Dashman T, Conney AH, Burns JJ. Effect of ascorbic acid on amine-nitrite toxicity. Ann NY Acad Sci 1975; 258: 169-73.
9. Schlegel JU. Proposed uses of ascorbic acid in prevention of bladder carcinoma. Ann NY Acad Sci 1975; 258: 432-6.
10. Raineri R, Weisburger JH. Reduction of gastric carcinogens with ascorbic acid. Ann NY Acad Sci 1975; 258: 181-8.
11. Howe, JGR, Hirohata T, Hislop TG, et al. Dietary factors and the risk of breast cancer: combined analysis of 12 case-controlled studies. J Natl Cancer Inst 1990; 82: 561-9.
12. Buiatti E, Palli D, Decarli A, et al. A case-controlled study of gastric cancer and diet in Italy: II Association with nutrients. Int J Cancer, 1990; 45: 896-901.
13. Duchesne J, Gilles R, Mosora F. Effet de substances anti-oxydantes sue le taux de radicaux libres organiques naturellement present dans le diaphragme du rat C.R. hebd. Seanc Acad Sci, Paris 1975; 281: 945-7.
14. Stankova L, Rigas DA, Keown P, Bigley R. Leucocyte ascorbate and glutathione: potential capacity for inactivating oxidants and free radicals. J Reticuloendoth Soc. 1977; 21: 97-102.
15. Slaga TJ, Bracken WM. The effects of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxylase. Cancer Res 1977; 37: 1631-5.
16. Prinz W, Bortz R, Bregin B, Hersch M. The effect of ascorbic acid supplementation on some parameters of the human immunological defense system. Int J Vitamin Nutr Res 1977; 47: 248-57.
17. Huwyler T, Hirt A, Morell A. Effect of ascorbic acid on human natural killer cells. Immunol Lett 1985; 10: 173-6.
18. Siegel BV, Morton JI. Vitamin C and immunity: natural killer (NK) cell factor. Int J Vitamin Nutr Res 1983; 53: 179-83.
19. Irwin MI, Hutchins BK. A conspectus of research on vitamin C requirements of man. J Nutr 1976; 106: 821-79.
20. Roder JC, Pross HF. The biology of human natural killer cell. J Clin Immunol 1983; 2: 249-63.
21. Jondal M. The human NK cell - a short over-view and an hypothesis on NK recognition. Clin Exp Immunol 1987; 70: 255-62.
22. Nino HV, Prasad AS. Vitamins and trace elements. In: Sonnenwirth AC, Jarett L, eds. Gradwohl's Clinical Laboratory Methods and Diagnosis, Vol 1. Toronto, London: The CV Mosby Comp, 1980: pp. 370-2.
23. Whiteside TL, Bryant J, Day R, Herberman RB. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J Clin Lab Anal 1990; 4: 102-14.
24. Fletcher MA, Baron GC, Ashman M, et al. Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol 1987; 5: 69-81.
25. Cameron E, Campbell A. The orthomolecular treatment of cancer. II Clinical trial of high-dose ascorbic supplements in advanced human cancer. Chem-Biol Interact 1974; 9: 285-315.
26. Moertal CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who had no prior chemotherapy. New Eng J Med 1985; 312: 137-41.
27. Helgestad J, Pettersen R, Strom-Mathisen I, Schjerven L. Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid. Eur J Haematol 1990; 44: 9-17.
28. 2 synthesis and implications for natural killer cell activity. Int J Vitamin Nutr Res 1984; 54: 339-42.
29. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992; 340: 1124-7.